Many of these same mediators—CGRP-driven matrix metalloproteinase induction, SP/NK1-R–mediated mitogenic signalling and PACAP-dependent cyclic-AMP modulation—are co-opted by glioblastoma cells to infiltrate neural parenchyma. The gene discussed is TACR1; the disease is glioblastoma.